At the GW Cancer Center, research drives innovation across the full spectrum of cancer discovery and care. Our investigators are leaders in basic science, translational innovation, prevention, and clinical application, working together to turn scientific insight into real solutions for patients and communities.
Research at GW extends far beyond any single method or setting. Investigators collaborate across laboratories, clinics, engineering environments, and community partners to develop new technologies, therapies, and approaches that change how cancer is detected, treated, and prevented.
Our research programs are intentionally structured to support this integrated pipeline, ensuring that discoveries do not stop at insight, but move forward into application and impact.
A Research Environment Built for Translation and Innovation
Advancing cancer science requires more than disciplinary excellence. It requires connection. At the GW Cancer Center, research programs are designed to link discovery, innovation, and application across institutional boundaries.
Basic scientists, engineers, clinicians, public health researchers, and implementation experts work side by side, sharing ideas, infrastructure, and expertise. This structure supports continuous movement from foundational discovery to technology development, early testing, and integration into patient care and prevention strategies.
Located in Washington, DC, GW benefits from proximity to federal agencies, research partners, and global health organizations. This environment enhances collaboration, accelerates innovation, and strengthens the pathways through which research findings influence cancer care and outcomes.
Research Programs That Advance Discovery and Application
The GW Cancer Center is organized around three research programs that reflect scientific strength, clinical opportunity, and public health need. Together, they support a cohesive research enterprise focused on innovation, translation, and impact.
Cancer Biology and Immunology
The Cancer Biology and Immunology Research Program (CBIP) advances fundamental understanding of the biological and immunologic mechanisms that underlie cancer. Investigators explore how cancers originate, evolve, and interact with the immune system, with a focus on mechanisms that drive progression, resistance, and response to therapy.
Research focus areas include:
- Tumor initiation, progression, and metastasis
- Cancer genetics, epigenetics, and molecular signaling pathways
- Tumor microenvironment and cell-to-cell interactions
- Cancer immunology and immune evasion mechanisms
- Mechanisms of therapeutic resistance
- Identification of novel molecular targets for treatment
This program provides the scientific foundation for innovation across the cancer center, fueling translational efforts in drug development, immunotherapy, and precision oncology.
Clinical and Translational Oncology
The Clinical and Translational Oncology Research Program (CTOP) is the engine that moves discovery into real treatments for patients. This program encompasses the full pathway from innovation to application, bridging scientific insight with clinical relevance.
Key areas include:
- Drug development and therapeutics
Preclinical testing, early-phase clinical trials, and evaluation of targeted and combination therapies - Engineering-driven innovation
Development of devices, drug delivery systems, and technology-enabled interventions to improve treatment accuracy and effectiveness - Cancer imaging and diagnostics
Advanced imaging modalities, radiomics, and biomarker development to support earlier diagnosis and real-time monitoring - Precision oncology
Integration of genomic and molecular profiling into individualized treatment strategies
Patients benefit from access to clinical trials and emerging therapies across GW and its partner institutions, including Children’s National Hospital and the DC VA Medical Center.
Cancer Control and Health Equity
The Cancer Control and Health Equity Research Program (CCHE) focuses on reducing cancer risk, improving early detection, and enhancing outcomes across populations. Investigators develop and test strategies that prevent cancer, support early diagnosis, and improve survivorship and supportive care.
Research focus areas include:
- Cancer epidemiology and risk factors
- Supportive care and survivorship
Interventions designed to improve symptom management, quality of life, and long-term outcomes - Screening and early detection
- Behavioral interventions and community engagement
- Implementation science and dissemination of evidence-based practices
- Health policy, access to care, and system-level interventions
This program emphasizes research that can be implemented in real-world settings, working in close partnership with communities, health systems, and public agencies to ensure that prevention and control strategies lead to measurable improvements in cancer outcomes.
Research With Reach and Relevance
Together, these research programs create a dynamic and collaborative environment that supports sustained excellence in cancer research. GW Cancer Center investigators generate discoveries that deepen understanding of cancer, drive technological and therapeutic innovation, and improve prevention and care for diverse populations.
By integrating biology, engineering, clinical insight, and population research, the GW Cancer Center advances science that informs practice and shapes the future of cancer care. This work strengthens health systems, improves outcomes, and contributes to a broader national and global effort to reduce the burden of cancer.
Grounded in rigorous scholarship and strengthened by collaboration across GW and beyond, the GW Cancer Center’s research enterprise is built to translate discovery into impact, today and in the future.